Table 2 Patient characteristics stratified based on histological subtypes
Histology subtypes | n(%) | Median age(range) | Overall survival (OS) | Cancer-specific survival (CSS) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean OS, m | Median OS, m | HR(95%CI) | P | Mean CSS, m | Median CSS, m | HR(95%CI) | P | |||
All patients | 1616 | 66.0(5–98) | 139.04 | 156.00 | / | / | 150.58 | 180.00 | / | / |
DLBCL | 927(57.4) | 69.0(13–98) | 127.55 | 133.00 | Reference | / | 143.25 | 169.00 | Reference | / |
MALT | 305(18.9) | 64.0(16–91) | 147.26 | 195.00 | 0.57(0.45–0.72) | < 0.001 | 145.45 | 175.00 | 0.77(0.61–0.98) | 0.033 |
FL | 152(9.4) | 60.5(30–93) | 176.98 | NR | 0.38(0.27–0.54) | < 0.001 | 170.76 | NR | 0.55(0.39–0.77) | 0.001 |
NHL-NOS | 102(6.3) | 70.5(13–95) | 118.93 | 135.00 | 0.97(0.70–1.33) | 0.824 | 146.68 | NR | 0.84(0.57–1.23) | 0.365 |
BL | 41(2.5) | 52.0(18–89) | 142.75 | NR | 0.46(0.24–0.89) | 0.022 | 149.96 | NR | 0.47(0.22–0.99) | 0.047 |
HL | 17(1.1) | 27.0(16–74) | 191.61 | NR | 0.19(0.05–0.75) | 0.018 | 191.61 | NR | 0.24(0.06–0.97) | 0.045 |
CLL/SLL | 13(0.8) | 76.0(47–92) | 92.96 | 159.00 | 1.25(0.59–2.63) | 0.563 | 108.62 | 159.00 | 1.43(0.64–3.21) | 0.384 |
Others | 59(3.7) | 67.0(5–98) | 110.62 | 76.00 | 1.23(0.85–1.78) | 0.275 | 137.89 | NR | 1.05(0.67–1.65) | 0.832 |